MiR-493-5p functions as a tumour suppressor in head and neck squamous cell carcinoma progression by targeting HIF-1α
MiR-493-5p, which targets HIF-1α and inhibits glycolysis and EMT, may be a novel therapeutic target for HNSCC.
Authors
- Dongxian Li (ORCID: https://orcid.org/0000-0003-0248-1584)
- Yu‐Hui Fang (ORCID: https://orcid.org/0000-0003-4319-2543)
- Caiyu Sun (ORCID: https://orcid.org/0000-0002-3001-5364)
- Shijun Lv
- Ruxian Tian
- Yumei Li (ORCID: https://orcid.org/0000-0003-2490-6889)
- Jiahui Liu (ORCID: https://orcid.org/0009-0003-2526-423X)
- Xi Chen (ORCID: https://orcid.org/0000-0002-2720-8843)
- Qing Song (ORCID: https://orcid.org/0000-0003-2716-6492)
- Xicheng Song (ORCID: https://orcid.org/0000-0002-9789-1318)
Institutions
- Qingdao University (CN)
- Binzhou Medical University (CN)
- Shandong University of Aeronautics (CN)
- Yuhuangding Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1007/s12672-025-02690-1
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00